Back to Search Start Over

Response to isolated limb perfusion and chemotherapy with epirubicin plus ifosfamide in a metastatic malignant ossifying fibromyxoid tumor.

Authors :
Provenzano, Salvatore
Raimondi, Alessandra
Bertulli, Rossella M.
Colia, Vittoria
Renne, Salvatore L.
Collini, Paola
Dagrada, Gianpaolo
Callegaro, Dario
Fiore, Marco
Greco, Francesca G.
Casali, Paolo G.
Source :
Clinical Sarcoma Research. 12/28/2017, Vol. 7, p1-6. 6p.
Publication Year :
2017

Abstract

Background: Ossifying fibromyxoid tumor (OFMT) is a rare soft tissue neoplasm of uncertain lineage and intermediate biological potential. It is more common in middle-aged men, usually arising from the deep tissues of the extremities. It is now established that it is a translocation related tumor, most often marked by translocation of PHF1 gene. Surgery is the mainstay of treatment and proves usually curative, although, in rarer cases the disease shows malignant features and tendency to recur both locally and at distant sites. In such cases, no standard treatment exists. Case presentation: We report on a case of malignant advanced OFMT of the hand with lung metastases responding to isolated limb perfusion with human recombinant tumor necrosis factor and melphalan and chemotherapy with epirubicin and ifosfamide. Conclusions: To our knowledge, this is the first report of activity of soft tissue sarcoma-oriented chemotherapy in advanced OFMT. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
20453329
Volume :
7
Database :
Academic Search Index
Journal :
Clinical Sarcoma Research
Publication Type :
Academic Journal
Accession number :
127067144
Full Text :
https://doi.org/10.1186/s13569-017-0086-2